reflect updat definit core financi measur exclud
intang asset amort charg impair except
is-rel intang
ep forecast revenu slightli light full year guidanc re-affirmed
ep estim ep guidanc
cer reiter estim fx impact unchang low singl digit
neg impact increas ep estim
reflect beat futur estim review
revenu estim
consensu collabor formerli extern revenu
forecast product sale estim
product beat estim includ nexium onglyza
pulmicort brilinta lynparza combin forecast
product estim includ forxiga tagrisso crestor
symbicort fasenra bydureon combin forecast
imfinzi sale line product sale guidanc exclud collabor
revenu remain intact high single-digit increas cer estim fx impact
unchang low singl digit neg last publish product sale estim
total revenu
gpm estim
estim sg estim oper
incom estim net financi expens
estim pre-tax margin estim tax rate
estim neg impact share count line
investor cash flow concern linger although manag note confid cover
dividend start capital-expenditure fund commit cash flow
model suggest azn correct
event expect includ imfinzi treme data/fil sschn bladder
nsclc sclc lynparza full data/fil pancreat cancer ph data ovarian
mcrpc trastuzumab deruxtecan data/fil advanc breast cancer farxiga
 approv roxadustat ph pool safeti data anemia file fasenra
 /eu approv self-administr brilinta full ph data themi /file
cad calquenc ph data/fil r/r cll investor event
chicago cdt complet list event shown follow page
pleas see page report import disclosur
azn promis new product pipelin particip mani larg
high growth market prospect could strengthen busi
development/partn ep growth appear industry-lead upsid possibl
azn guidanc deliv azn progress dividend polici intact
sum azn outlook one strongest pharma argu purchas share
uptak new product notabl
tagrisso imfinzi lynparza fasenra
full phase data brilinta themi
improv diabet respiratori
new product unabl sustain share
diabet respiratori franchis lag
astrazeneca biopharmaceut compani domicil key product area
cardiovascular diabet respiratori oncolog
cowen compani
cowen compani
reportedour estimatedifferenceproduct exceed line cowen
cowen compani
cowen compani
time frameev top-lin data sle miss endpoint aug phase themi data cad posit top-lin feb data r/r cll data hfeef dapa-hf tremelimumabphas ii data sschn kestrel data danub bladder cancer data neptun nsclc data poseidon nsclc data caspian sclc w/mrk full data polo pancreat cancer met primari endpt ascoful phase data solo brcam ovarian cancer posit top-lin dec data ovarian mainten w/avastin regardless brca statu data mcrpc tripl phase data etho copd exacerb pool safeti data anemia full data olympu rocki posit top-lin dec os data egfr nsclc flaura ascotrastuzumab deruxtecan ii data breast cancerregulatorybevespijp/cn approv copd file cad themi file cll approv file declar cv data approv self-administration/auto-injector tremelimumabregulatori file bladder cancer danub regulatori file lung cancer neptun file lung cancer poseidon file sclc caspian file sschn kestrel regulatori file hyperkalemialynparza w/mrk eu/jp/cn approv brcam ovarian cancer file pancreat cancer file brcam ovarian approv copd file copd file anemia approv anemia dialysi patientsselumetinib w/mrk regulatori file neurofibromatosi type approv mild asthma approv egfr nsclc deruxtecan file advanc breast cancer event ascojun chicago cdt cowen
valuat methodolog primarili base current year forward price-to-earnings multipl
also consid total return/p ratio market cap/fre cash flow metric
failur pipelin product intellectu properti challeng econom sensit
price pressur and/or weaken consum demand develop market econom
and/or polit uncertainti emerg market chang tax law outlook
dividend fluctuat foreign exchang rate
risk includ continu success exist portfolio notabl crestor brilinta
success pipelin product success deal patent litig patent
expir pressur uncertainti strateg direct could includ
outlook dividend
author research report herebi certifi view express research report accur reflect person view subject
secur issuer ii part compens relat directli indirectli specif recommend view express report
cowen compani llc affili make market stock astrazeneca plc adr novarti adr roch hold ltd adr secur
cowen compani llc act underwrit announc initi public offer elanco anim health incorpor subsidiari co
cowen compani llc act financi advisor inc connect acquisit roch hold ag announc februari
cowen compani llc compens research analyst activ servic intend benefit firm investor client individu compens determin research
analyst includ author report base varieti factor includ overal profit firm total revenu deriv sourc includ
revenu invest bank sale trade princip trade revenu cowen compani llc compens research analyst base specif invest
bank transact specif sale trade princip trade revenu
research report simultan avail client client websit research report client research report dissemin e-mail
made avail third-parti aggreg cowen compani llc respons redistribut research third parti aggreg select research report
avail print form addit electron form publish research report obtain firm client websit http //cowenlibrari bluematrix com/client/
inform opinion estim forecast date report subject chang without prior notif seek updat research appropri
variou regul may prevent us research report publish irregular interv appropri analyst judgement
inform subject secur may obtain offic research report publish sole inform purpos constru offer
sell solicit offer buy secur state offer solicit would illeg disclosur relat cowen compani llc
inform herein base sourc believ reliabl guarante us purport complet statement summari avail data
opinion express herein statement judgment date subject chang without notic opinion recommend herein take
account individu client circumst object need intend recommend invest strategi recipi report must make
independ decis regard secur subject research report case secur financi instrument may difficult valu sell reliabl
inform valu risk relat secur financi instrument may difficult obtain extent report discuss legal proceed issu
prepar express intend express legal conclus opinion advic salespeopl trader profession may provid oral written
market commentari trade strategi client reflect opinion contrari opinion express research princip trade area invest
busi may make invest decis inconsist recommend view express research cowen compani llc maintain physic electron
procedur inform barrier address flow inform among depart within cowen compani llc order prevent avoid conflict
interest respect analyst recommend
import disclosur regard compani subject research report pleas contact complianc depart cowen compani llc lexington
